Entera Bio
ENTX
5 hedge funds and large institutions have $3.42M invested in Entera Bio in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and 0 closing their positions.
67% more funds holding
Funds holding: 3 → 5 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.24% less ownership
Funds ownership: 10.94% → 10.7% (-0.24%)
9% less capital invested
Capital invested by funds: $3.78M → $3.42M (-$359K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
+$61.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$21.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM
Wildcat Capital Management
New York
|
-$99.2K |
| 2 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$65.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KCM
1
Knoll Capital Management
Miami,
Florida
| $3.01M | – | – | – |
|
|
WCM
2
Wildcat Capital Management
New York
| $269K | -$99.2K | -48,600 | -27% |
|
|
PF
3
Phoenix Financial
Givatayim,
Israel
| $66K | -$65.2K | -31,955 | -46% |
|
|
WS
4
Wedbush Securities
Los Angeles,
California
| $55K | +$61.2K | +30,008 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $19K | +$21.2K | +10,382 | New |
|
ENTX Hedge Fund Activity: Q2 2020 in Review
5 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q2 2020, worth a combined $3.42M — down 9.5% from $3.78M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ENTX positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Wedbush Securities, opening a new position worth an estimated $61.2K. The largest seller was Wildcat Capital Management, cutting an estimated $99.2K.
- 5 institutional investors held Entera Bio (ENTX) as of Q2 2020, up from 3 in Q1 2020.
- Funds reported $3.42M of Entera Bio stock for Q2 2020, down 9.5% quarter-over-quarter.
- 2 funds opened new Entera Bio positions in Q2 2020 and 0 closed out, a net change of +2 holders.
- The largest Entera Bio buyer in Q2 2020 was Wedbush Securities, an estimated $61.2K added.
- The largest Entera Bio seller in Q2 2020 was Wildcat Capital Management, an estimated $99.2K sold.
Based on aggregated 13F filings for Q2 2020.